Trials / Withdrawn
WithdrawnNCT03964597
Objective Measurements of Lens Opacification After Intravitreal Injections
Objective Measurements of Lens Opacification After Intravitreal Injections (MOC-IVT)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main hypothesis is the opacification of the lens would be increase by the IVT. The opacification of the lens can be objectived by : * the objective scatter index (OSI) on the OQAS device * the average lens density (ALD) on the IOLMaster device. Eligible patients will be followed at least 12 months after in intravitreal injection and the opacification of their lens is regularly controlled with OSI and ALD. The objective is to study the dynamics of lens opacification in IVT-treated eyes evaluated by OSI for at least 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Measurement of lens opacification | Measurement of OSI and ALD at inclusion and during post-IVT follow-up visits to M3, M6, and M12, +/- M18, +/- M24 and +/- M30. |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2019-09-01
- Completion
- 2019-09-01
- First posted
- 2019-05-28
- Last updated
- 2020-01-22
Source: ClinicalTrials.gov record NCT03964597. Inclusion in this directory is not an endorsement.